Kinetic Models for Measuring P-glycoprotein Function at the Blood-Brain Barrier with Positron Emission Tomography

Publisher： Bentham Science Publishers

E-ISSN： 1873-4286|22|38|5786-5792

ISSN： 1381-6128

Source： Current Pharmaceutical Design, Vol.22, Iss.38, 2016-11, pp. : 5786-5792

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Blood-Brain Barrier P-Glycoprotein Function in Neurodegenerative Disease

By  

Current Pharmaceutical Design, Vol. 17, Iss. 26, 2011-09 ,pp. : 2771-2777

Bentham Science Publishers

Access to resources Recommend Favorite

Blood–Brain Barrier Penetration of Zolmitriptan—Modelling of Positron Emission Tomography Data

By Bergström Mats   Yates Roger   Wall Anders   Kågedal Matts   Syvänen Stina   Långström Bengt  

Journal of Pharmacokinetics and Pharmacodynamics, Vol. 33, Iss. 1, 2006-02 ,pp. : 75-91

Springer Publishing Company

Access to resources Recommend Favorite

Effect of endotoxin on doxorubicin transport across blood-brain barrier and P-glycoprotein function in mice

By Zhao Y.L.   Du J.   Kanazawa H.   Sugawara A.   Takagi K.   Kitaichi K.   Tatsumi Y.   Takagi K.   Hasegawa T.  

European Journal of Pharmacology, Vol. 445, Iss. 1, 2002-06 ,pp. : 115-123

Elsevier

Access to resources Recommend Favorite

PET Studies on P-Glycoprotein Function in the Blood-Brain Barrier: How it Affects Uptake and Binding of Drugs within the CNS

By  

Current Pharmaceutical Design, Vol. 10, Iss. 13, 2004-05 ,pp. : 1493-1503

Bentham Science Publishers

Access to resources Recommend Favorite

P-glycoprotein mediates brain-to-blood efflux transport of buprenorphine across the blood-brain barrier

By Suzuki Toyofumi   Zaima Chika   Moriki Yoshiaki   Fukami Toshiro   Tomono Kazuo  

Journal of Drug Targeting, Vol. 15, Iss. 1, 2007-01 ,pp. : 67-74

Informa Healthcare

Access to resources Recommend Favorite